Montekis-FX

Montekis-FX by Biocuris is a comprehensive anti-allergy formulation combining Montelukast Sodium and Fexofenadine Hydrochloride Tablets IP, developed under the trusted brand promise — “Quality with Integrity”. This dual-action tablet is specifically designed to provide superior relief from allergic conditions by targeting both the inflammatory and histamine-mediated pathways of the allergic response.

Montelukast Sodium is a leukotriene receptor antagonist (LTRA) that works by blocking the action of leukotrienes — chemical messengers released by the immune system during an allergic reaction. Leukotrienes cause bronchoconstriction (narrowing of airways), increased mucus secretion, swelling of nasal passages, and recruitment of inflammatory cells. By inhibiting these effects, Montelukast reduces both early and late-phase allergic responses, making it highly effective for allergic rhinitis and asthma.

Fexofenadine Hydrochloride is a third-generation, non-sedating antihistamine that selectively blocks peripheral H₁ histamine receptors. Histamine is a key mediator responsible for classic allergy symptoms such as sneezing, itching, watery eyes, runny nose, and hives. Unlike older antihistamines, Fexofenadine does not cross the blood-brain barrier significantly, meaning it provides powerful allergy relief without causing drowsiness, sedation, or cognitive impairment.

Together, these two complementary mechanisms provide a synergistic effect:

• Fexofenadine rapidly controls acute symptoms like sneezing, itching, and runny nose

• Montelukast addresses underlying inflammation, nasal congestion, and respiratory symptoms

Montekis-FX is clinically indicated for:

• Seasonal allergic rhinitis (hay fever) and perennial allergic rhinitis

• Allergic asthma – especially when triggered by allergens

• Chronic urticaria (hives) – long-lasting itchy skin rashes

• Exercise-induced bronchoconstriction

• Allergic conjunctivitis (eye allergies) as part of systemic treatment

This fixed-dose combination offers convenient once- or twice-daily dosing, reducing pill burden while maximizing therapeutic outcomes. Montekis-FX is suitable for adults and children above 12 years of age. Packaged in a 10×10 tablets configuration (100 tablets total), it ensures consistent, long-term allergy management.

Key Benefits:

• Dual Anti-Allergy Action – Antihistamine + leukotriene inhibitor for complete relief.

• Non-Drowsy Formula – Fexofenadine does not cause sedation or sleepiness.

• 24-Hour Relief – Controls sneezing, runny nose, itching, and nasal congestion.

• Asthma & Allergy Combo – Effective for patients with both conditions.

• Reduces Inflammation – Montelukast targets underlying allergic inflammation.